The following clinical trials for TNBC, HER2 positive, and other subtypes of metastatic (stage IV) breast cancer have just been added to BreastCancerTrials.org (BCT) in the last month. These clinical trials can also be found on Metastatic Trial Search (MTS).

Stage IV Triple Negative Breast Cancer (TNBC)

• Comparing an Experimental form of Docetaxel to Standard Docetaxel in Women with Advanced Triple Negative Breast Cancer

Stage IV HR Positive (ER+ and/or PR+) Breast Cancer

• Imaging to Personalize Amount of Tamoxifen in Advanced, ER+, HER2- Breast Cancer With a ESR1 Mutation
• Targeted Therapy SY 5609 in Advanced, Hormone Positive, HER2 Negative Breast Cancer
• H3B-6545 & Palbociclib for Women with Advanced ER+, HER2- Breast Cancer

Stage IV HER2 Positive Breast Cancer 

• SBT6050 for Advanced HER2 Expressing Breast Cancer

Stage IV Breast Cancer With BRCA Mutation

• PARP Inhibitor Olaparib with Cediranib or Ceralasertib for Women with Advanced, HER2-, Inherited BRCA+ Breast Cancer

Other Stage IV Breast Cancer

• Metarrestin (ML-246) for Metastatic Breast Cancer

Last Modified on October 2, 2020